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Abstract
Background: Human-induced pluripotent stem cells (hiPSCs) are a potentially invaluable resource for regenerative
medicine, including the in vitro manufacture of blood products. HiPSC-derived red blood cells are an attractive
therapeutic option in hematology, yet exhibit unexplained proliferation and enucleation defects that presently
preclude such applications. We hypothesised that substantial differential regulation of gene expression during
erythroid development accounts for these important differences between hiPSC-derived cells and those from adult
or cord-blood progenitors. We thus cultured erythroblasts from each source for transcriptomic analysis to
investigate differential gene expression underlying these functional defects.
Results: Our high resolution transcriptional view of definitive erythropoiesis captures the regulation of genes
relevant to cell-cycle control and confers statistical power to deploy novel bioinformatics methods. Whilst the
dynamics of erythroid program elaboration from adult and cord blood progenitors were very similar, the emerging
erythroid transcriptome in hiPSCs revealed radically different program elaboration compared to adult and cord
blood cells. We explored the function of differentially expressed genes in hiPSC-specific clusters defined by our
novel tunable clustering algorithms (SMART and Bi-CoPaM). HiPSCs show reduced expression of c-KIT and key
erythroid transcription factors SOX6, MYB and BCL11A, strong HBZ-induction, and aberrant expression of genes
involved in protein degradation, lysosomal clearance and cell-cycle regulation.
Conclusions: Together, these data suggest that hiPSC-derived cells may be specified to a primitive erythroid fate,
and implies that definitive specification may more accurately reflect adult development. We have therefore
identified, for the first time, distinct gene expression dynamics during erythroblast differentiation from hiPSCs which
may cause reduced proliferation and enucleation of hiPSC-derived erythroid cells. The data suggest several
mechanistic defects which may partially explain the observed aberrant erythroid differentiation from hiPSCs.
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Background
Definitive erythropoiesis in mammals replenishes the
circulating pool of red blood cells (RBCs) and is con-
trolled by intrinsic and extrinsic factors, notably cyto-
kines that induce/select lineage commitment and
differentiation from the hematopoietic stem cell (HSC).
Two distinct programs of mammalian erythropoiesis
have been elucidated through the use of human embry-
onic stem (ES) cells and murine studies to describe
transcriptional and morphological changes during
hematopoiesis [1–4]. In the first trimester, hematopoietic
precursors in the fetal yolk sac follow a primitive
erythropoietic program. In the second trimester, HSCs
from the fetal liver and bone marrow yield enucleated
erythrocytes via a definitive program of erythropoiesis.
Production of erythroid progenitors from hematopoietic
stem/progenitor cells (HSPCs) in vitro recapitulates this
definitive process using specific cytokines (IL-3, IL-6 and
stem cell factor (SCF)), generating progenitors with mega-
karyocyte/erythroid potential (MEPs) and then committed
erythroid cells. Initially, CD34+ cells barely proliferate as
progenitors but are selected and/or programmed for ex-
pansion, becoming dependent on erythropoietin (EPO)
and SCF for their survival [5].
The developing erythroid progenitors then expand rap-
idly as proerythroblasts undergo changes in morphology
and cell surface phenotype, including acquisition of the
lineage marker glycophorin A (GYPA, CD235a). After sev-
eral rounds of expansion, maturation proceeds with vast
synthesis of hemoglobin before chromatin condensation
and enucleation produces reticulocytes that develop
further in the bone marrow, circulation and spleen. Up-
regulation of erythroid transcription factors (TFs) such as
GATA1, SCL/TAL1 and KLF1, and down-regulation of
TFs specific to other lineages, chromatin modifier proteins
and enhancer elements, co-operatively form a transcrip-
tional network that drives red cell development [6–8].
Erythroid cultures derived from human CD34+ pro-
genitors in cord and/or peripheral blood have been used
to describe physiological and pathological erythroid tran-
scriptomes and associated TF activity [9, 10]. Erythroid
cultures derived from embryonic stem cells or human
induced pluripotent stem cells (hiPSCs) have also been
investigated for their clinical potential [11–14]. These
hiPSC lines have been used to model erythropoiesis in
individuals with genetic disorders and suggest the possi-
bility of deriving engineered transfusable RBC products
or transplantable stem cells [15–22]. However, at the
time of writing, no data has been generated to assess the
fidelity of erythroid gene expression changes with time
during erythropoiesis from hiPSCs in comparison with
adult progenitors.
Red cells derived from hiPSCs can express many of
the proteins required for normal erythrocyte function
[23]. In vitro this includes hemoglobin A [14], and in
vivo they are able to switch from fetal to adult
hemoglobin [24]. However, expansion and enucleation
rates from hiPSC-derived erythroblasts are much lower
than observed with erythroblasts derived from adult or
cord blood [12, 24]. The causes of these differences are
unclear, but are presumably driven by differences in gene
expression that can be identified in dynamic transcrip-
tomic analyses.
Previously we have described the erythropoietic tran-
scriptome in vitro using staged populations of sorted
erythroblasts grown from adult peripheral blood progeni-
tors [25]. This and other papers describing erythropoiesis
from CD34+ progenitors [26–29] have typically yielded a
relatively small number of staged samples for comparison.
Transcriptome analysis of samples representing more
stages through erythropoiesis (during a period of marked
morphogenetic remodelling) improves the statistical
power of bioinformatic approaches [28, 30, 31].
We therefore extended our prior observations by further
subdividing erythropoietic cultures derived from adult
hematopoietic progenitors to increase the number of staged
populations studied that allowed use of our novel algo-
rithms to cluster co-expressed genes in an unsupervised
and tunable manner [30, 31]. These algorithms were used
to define co-ordination of gene expression during erythro-
poiesis from adult, cord blood and hiPSC hematopoietic
progenitors. With this approach we have been able to iden-
tify, for the first time, robust and specific patterns of gene
regulation from hiPSC progenitors which differ markedly
from those observed in adult- and cord-derived erythro-
blasts, and which may, at least in part, cause reduced prolif-
eration and enucleation of erythroid cells from hiPSCs.
Results
Transcriptome analysis of adult erythropoiesis
CD34+ HSPCs from adult peripheral blood were cul-
tured in SEM-F (Table 1 and Additional file 1: Figure
S2A), which contained FBS, EPO, SCF, dexamethasone
and IL-3. Triplicate samples representing 7 well-defined
stages were obtained with distinct morphological and
phenotypic characteristics (Additional file 1: Figure S2B).
Each population corresponded to erythropoietic stages
of differentiation sampled from day 0 to day 14 of
culture. Cultures yielded ~10,000-fold expansion of the
original CD34+ cells to pyknotic erythroblasts on day 14
(Additional file 1: Figure S2C).
Data resulting from hybridisation of total RNA from
these cells to Affymetrix HTA microarrays was analysed
for differentially expressed genes as cells progressed
through different erythropoietic stages (Additional file 1:
Figure S2D).
Principal component analysis (PCA) demonstrated a
large distance between the samples from day 0 and
Merryweather-Clarke et al. BMC Genomics  (2016) 17:817 Page 2 of 20
all later samples (Fig. 1a). Surprisingly, we detected
relatively small distances between clusters of samples
from progressive population types during the early
phases of erythropoiesis (day 4, day 7−, day7+, and
day 10). However, there is a more dynamic phase of
gene expression changes late in maturation as cells
prepare for enucleation (days 12 to 14) (Fig. 1a and
Additional file 2: Table S1A, and S1B), consistent
with our previous data [25]. Hierarchical clustering of
the transcriptome data delineated well-defined pat-
terns of gene expression changes that characterise
erythropoiesis. This erythroid program is broadly seg-
regated into 3 blocks of genes: one expressed at day
0 then repressed; another transiently up-regulated at
days 4-10; and one other induced late in differenti-
ation (Fig. 1b and Additional file 3: Figure S4). This
pattern of transcriptional changes implied in the PCA
and hierarchical clustering analysis was confirmed by
enumeration of individual transcript expression
changes through erythroid maturation (Fig. 1b and c
and Additional file 3: Figure S4).
Confirmation and comparison of transcriptomes from
adult erythropoiesis
Our previously-described erythroid-induced genes [25]
are predominantly up-regulated in our current data
(Additional file 2: Table S1A, and Additional file 4: Table
S2). Furthermore our dataset contains examples of up-
regulated erythroid specific genes, such as kruppel-like
factor- erythroid (KLF1), which had not been identified
in our previous dataset. Indeed, an additional 1573
differentially expressed genes are added whose regula-
tion was not detected in our previous approach (Fig. 1b
and Additional file 4: Table S2).
We also examined genes expressed preferentially in
staged ex vivo-isolated primary human erythroid cells
[32] for their expression in our data. These genes are
indeed induced during elucidation of the erythroid gene
expression program (Fig. 1d) and include important
erythropoietic regulators such as SCL/TAL1, NFE2,
BCL2L1, BCL2L11, BCL6 and SOX6.
Gene ontology (GO) analysis identified early induction
of genes encoding cell-cycle proteins including cyclins
Table 1 Standard Erythroid Media (SEM) components. Erythroid progenitors were cultured in two Standard Erythroid Medium


















Fetal Bovine Serum (FBS) Sigma 2 % 2 % 2 % 3 % 3 % 3 % 3 %
Penicillin Sigma 100 U/ml 100 U/ml 100 U/ml 100 U/ml 100 U/ml 100 U/ml 100 U/ml
Streptomycin Sigma 100 μg/ml 100 μg/ml 100 μg/ml 100 μg/ml 100 μg/ml 100 μg/ml 100 μg/ml
Glutamine Sigma 4E-3M 4E-3M 4E-3M 4E-3M 4E-3M 4E-3M 4E-3M
Human AB serum Sigma 3 % 3 % 3 % 2 % 2 % 2 % 2 %
Folic Acid Sigma 10 μg/ml 10 μg/ml 10 μg/ml 10 μg/ml 10 μg/ml 10 μg/ml 10 μg/ml
Inositol Sigma 40 μg/ml 40 μg/ml 40 μg/ml 40 μg/ml 40 μg/ml 40 μg/ml 40 μg/ml
Holotransferrin Sigma 200 μg/ml 1 mg/ml 1 mg/ml 120 μg/ml 120 μg/ml 1 mg/ml 1 mg/ml
Human Recombinant
Erythropoietin (Epo)
Janssen 3 U/ml 3 U/ml 3 U/ml 3 U/ml 3 U/ml 3 U/ml 3 U/ml
Insulin Sigma 10 μg/ml 10 μg/ml 10 μg/ml 10 μg/ml 10 μg/ml 10 μg/ml 10 μg/ml
Monothioglycerol Sigma 1.6E-4M 1.6E-4M 1.6E-4M 1.6E-4M 1.6E-4M 1.6E-4M 1.6E-4M
Cholesterol-Rich Lipids Sigma 40 μg/ml 40 μg/ml 40 μg/ml 40μg/ml 40μg/ml 40μg/ml 40 μg/ml
Heparin Sigma 3 U/ml 3 U/ml 3 U/ml 3 U/ml 3U/ml 3U/ml 3 U/ml
Human Stem Cell Factor
(SCF)
R&D Systems 100 ng/ml 100 ng/ml 0 100 ng/ml 100 ng/ml 100 ng/ml 0
Dexamethasone Sigma 1E-6M 0 0 1E-6M 1E-6M 1E-6M 1E-6M
IL3 R&D Systems 1 ng/ml 0 0 5ng/ml 5ng/ml 0 0
FLT3 Ligand R&D Systems 0 0 0 20 ng/ml 20 ng/ml 20 ng/ml 0
IL6 R&D Systems 0 0 0 10 ng/ml 0 0 0
Thrombopoietin R&D Systems 0 0 0 20 ng/ml 0 0 0
IMDM Iscove’s Modified Dulbecco’s Medium; IL3 interleukin-3; BSA bovine serum albumin; FLT3 Fms-like tyrosine kinase 3; IL-6 interleukin-6
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and cyclin-dependent kinases and the origin recogni-
tion/minichromosome licensing complex (Table 2).
These data are consistent with the emergence of prolif-
erative erythroblasts from the CD34+ HSPCs. Indeed,
late in differentiation when proliferation declines, many
of these transcripts encoding elements of the cell-cycle
machinery are repressed while negative cell-cycle regula-
tors such as CDKN1B/p27KIP1 and CDKN2C/p18 are in-
duced (Additional file 2: Table S1A, and Additional file 4:
Table S2). Thus taken together, these observations of
staged populations suggest that we have captured the co-
ordinated up- and down-regulation of overlapping gene
d4 36+ 71+ 235-
d0 34+
d7 36+ 71+ 235-
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Fig. 1 Gene expression during erythroid differentiation from adult stem cells in SEM-F. a PCA of differential gene expression in the
triplicate AB FBS samples transforms the data into a series of uncorrelated variables made up from linear combinations and shows, in an
unsupervised analysis, the progression of the differentiating erythroid cells through gene expression state-space. Genes reaching a minimum linear
expression value of 100 in all replicates of at least one sample group were selected as differentially-expressed (DE) between any two stages during
erythroid differentiation if they met the following criteria: p≤ 0.01, fold change (FC)≥ 2, B > 2.945 (Additional file 2: Table S1A). The union of all DE
genes was used in the PCA. The Euclidean distances relating to this PCA are available in Additional file 19: Table S6. b Hierarchical clustering analysis of
the differentially-expressed genes used in (A), clustering by gene only according to Euclidean distance. The colour bar on the left hand side denotes
clusters of co-regulated genes. c Plot showing the number of differentially-expressed genes between consecutive populations in the adult FBS
time-course data. d Genes described to be preferentially expressed in primary human erythroid cells [32] were examined in our current adult SEM-F
dataset. Where these genes were expressed in our data, their expression pattern is shown as a hierarchical clustering, clustered by gene
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expression programs relevant to cell-cycle control during
erythropoiesis and as seen in primary erythroblasts ex
vivo.
Comparison of adult and cord blood erythroid programs
We wanted to establish whether similar patterns of gene
expression could be observed during erythroid expan-
sion from cord blood HSPCs cultured in the same
media, SEM-F. We compared samples prepared at the
most dynamic phase of gene expression between days 7
and 14 (Fig. 2 and Additional file 5: Table S3A and S3B).
First, developing erythroid cells from adult or cord
HSPCs have broadly similar emergent transcriptomes:
PCA shows adult peripheral blood and cord blood
samples cluster together in domains separated by time
from the day 0 CD34+ populations to the day 14 sam-
ples, but do not differ significantly by source (Fig. 2a).
Hierarchical clustering analysis shows adult and cord
blood samples largely co-regulate blocks of genes whose
expression is similar in both cell types (Fig. 2b, Table 3
and Additional files 6 and 7: Figures S5A and B).
The difference in the number of genes differentially
regulated between developing erythroid cells derived
from adult and neonatal progenitors is greater at the
CD34+ stage (day 0) than later (Table 3). This suggests
convergence of similar fates in SEM-F despite apparent
differences in the CD34+ compartment from adult and
cord blood (Fig. 2c). We used GO analysis to identify
groups of genes enriched for cellular components or
molecular processes (Table 4) that were similar between
cord and adult expression profiles. These findings are
summarised in Additional file 5: Tables S3A and S3B. As
well as key erythroid transcription factors GATA1 and
KLF1 (Fig. 2d), the gamma globin gene, HbG2 is also
up-regulated equally in both profiles (Additional file 4:
Table S2). Whilst non erythroid transcription factors and
regulators are down-regulated in the first 7 days of dif-
ferentiation, FLI1, ERG, JUN, FLT3, ETV6, notably MYB
and c-KIT are down-regulated between days 7 and 14
(Fig. 2d and Additional files 6: Figure S5A and 7: Figure
S5B). Once we had validated our in vitro culture system
and shown the high similarity of adult and neonatal eryth-
roid gene expression dynamics, we repeated the adult
transcriptional analysis using SEM-i (Table 1), a medium
that has been shown to yield maximal erythropoiesis from
OP9 derived hiPSCs (see Methods). Crucially, adult eryth-
roid development was largely unaffected by SEM-i when
compared to SEM-F (Fig. 3a, b, Table 5; Additional
file 8, Figure S6 and Additional file 9, Figure S7).
Thus, we could reliably compare the elaboration of
the erythroid program from adult and hiPSC-derived
cells-of-origin in SEM-i.
hiPSC-derived erythropoiesis
The degree to which hiPSC-derived erythropoiesis re-
flects normal erythroid development is unclear. Cer-
tainly, erythroid cells derived from hiPSCs show reduced
growth and enucleation compared to erythroid cells
from adult or cord blood (Fig. 3c and d).
For comparison with the AB- and CB-erythroblast data,
we examined transcriptional changes during erythropoi-
esis from three different hiPSC lines in SEM-i (Additional
file 10: Table S5A and S5B). PCA analysis revealed that
the hiPSC-derived samples clustered quite separately from
the adult samples (Fig. 4a).
Erythroblasts derived from hiPSCs up-regulate genes
encoding proteins involved in heme biosynthesis includ-
ing CPOX, PPOX, FECH, HMBS, UROD, ALAS2, and
SLC25A39 somewhat earlier than the adult-derived cells,
where expression of these genes peaked later, between
days 7 and 14 (Additional file 11: Figure S8). Concerted
up-regulation of cell-cycle genes in the adult samples
was noted by day 7, but expression of this set of genes
was more limited in intensity and breadth in the hiPSCs
(Additional file 12: Figure S9).
Although we observed similar expression of the gamma
globin gene HBG2 in erythroblasts from adult and hiPSC
progenitors (Additional file 4: Table S2), a significant clue
to the different erythropoietic program observed from
hiPSCs was the apparent development of a primitive
erythropoietic globin profile, as described previously in
hiPSCs [18], and in human embryonic stem cells [33].
Whereas adult-derived cells gradually up-regulated HBB
and HBA, hiPSC-derived cells expressed HBA and the em-
bryonic globin HBZ (Fig. 4b). In contrast the adult-
derived erythroblasts neither significantly expressed nor
appreciably induced HBZ, consistent with a definitive
erythropoietic profile (Additional file 13: Figure S10B).
Table 2 Genes differentially expressed (DE) (B value at least 2.945,
p-value below 0.01, fold change at least 2, and expression levels in
all replicates at any population at least 100) during maturation of
adult erythroblasts in SEM-F were selected as shown, and submitted
to gene ontology analysis using GeneCoDis
Comparison GO category Corrected Hyp.
p Value
Upregulated d0 to d4 Mitotic cell cycle 2e−91






Upregulated d12 to d14 Nucleus/cell cycle arrest 7e−6
Downregulated d12 to d14 Purine metabolism 4e−11
Ribosome biosynthesis 8e−9
Mitotic cell cycle 7e−8
Significantly-scoring ontologies are shown, together with p-values presented
as the more stringent corrected hypergeometric (Hyp) p-values produced
by GeneCoDis
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Together, these data strongly suggest that these
hiPSC-derived erythroblasts follow the embryonic or
primitive program of hematopoiesis which is signifi-
cantly different from the gene expression program delin-
eated during erythroid development from adult HSPCs.
Functional gene clusters
We and others [12, 18, 23] have noted that hiPSC-
derived erythroblasts fail to enucleate as efficiently in
vitro as adult-derived cells (Fig. 3d). Subsequently, we
set out to identify clusters of genes whose expression
correlated with these functional defects. First, we
closely examined the expression of genes that regulate
and co-ordinate erythroid development or have key
functional roles in erythroid cells across all three
datasets. We noted that transcripts such as GATA1,
TAL1, KLF1, EPOR and ANK1 are induced in both
hiPSC-derived erythroblasts and in the adult setting
(Additional file 4: Table S2 and Additional file 14:
Figure S10A); other regulatory genes such as the AP-1
components JUN, JUNB, JUND, FOS and FOSB are
expressed more highly in the adult cells prior to eryth-
roid differentiation – thereafter expression dynamics
are similar in adult and hiPSC-derived erythropoiesis
(Additional file 14: Figure S10A).
In keeping with their apparent primitive erythropoietic
globin gene expression profile, the key erythroid TFs
SOX6, MYB and BCL11A are all expressed at much
lower levels in hiPSC-derived erythroblasts compared
with adult blood (Fig. 4c). We validated expression of
these genes and others by quantitative RT-PCR
(Additional file 13: Figure S10B). In murine erythropoi-
esis, these TFs are expressed in definitive blood cells
(reviewed by Palis [34]) and function in switching globin
expression from fetal to adult hemoglobin [35–37]. Fi-
nally, ARID3A expression, specific to primitive erythro-
poiesis [38], is poor in adult- but strong in hiPSC-
derived erythropoiesis (Fig. 4c and Additional file 13:
Figure S10B). Gene expression program differences vis-
ible in the PCA (Fig. 4a) are also evident in Hierarchical
clustering analysis (Fig. 4d).
We noted in relation to the radically different prolifer-
ation of adult and hiPSC-derived erythroblasts (Fig. 3c)
that the key erythroid genes KIT and NFIA [39] are
expressed less in hiPSC-derived erythroid cells than in
the adult-derived setting (Fig. 4e and Additional file 13,
Figure S10B). We postulated that low expression of c-
KIT in hiPSCs versus adult erythroblasts might be
responsible for the failure of the hiPSCs to proliferate in
response to SCF in the culture media. Therefore we uti-
lised a lentiviral expression construct to enforce c-KIT
expression in hiPSC-derived progenitors. Transduced
cells were then isolated by flow sorting and their prolif-
eration tracked. We found that cells transduced with c-
KIT proliferated more than cells transduced with the
control vector (Fig. 5a) which offers mechanistic
support for potentially improving erythroblast yield via
signalling through c- KIT.
Upstream TFBS analysis from gene clusters and erythroid
regulatory genes
Given the biological differences between the terminal
erythroid cells produced from different HSPCs, we pro-
ceeded to utilise SMART (splitting merging awareness
tactics) [31] to allow us to identify co-ordinately-
regulated clusters of genes which might be relevant to
the differences in enucleation and proliferation observed
in hiPSC differentiation compared to adult or neonatal
stem/progenitor differentiation (Fig. 6a).
We examined clusters containing more than 30
genes for evidence of differential regulation between
adult and cord blood samples and the hiPSC-derived
cells. Several clusters were identified that fit this pro-
file (Fig. 6a and Additional file 6: Figure S5A and
Additional file 15: Figure S11).
These differentially-regulated clusters (10, 13, 16, 17,
19–24, 26–29, 32–35, Additional file 15: Figure S11)
were scrutinised for genes with potential functional roles
in either proliferation or enucleation. Examining the
functional clusters for enriched gene ontologies was
largely unproductive, partially due to the small number
of genes contained within each cluster. However, we ob-
served the highly significant co-regulation of genes in-
volved in DNA repair processes in cluster 20, together
with other genes involved in cell-cycle regulation. These
genes (FANCA, FANCB, FANCC, FANCD2, BRCA2 and
RAD51) were examined for conserved upstream tran-
scription factor binding motifs, and were found to be as-
sociated with enrichment of putative PITX and FOXJ
motifs (Fig. 6b), suggesting putative regulators of expres-
sion for this functional gene cluster. Moreover, PITX1
expression increased steadily during erythropoiesis from
adult and cord blood-derived cells, but failed to increase
during hiPSC-derived erythropoiesis (Additional file 4:
Table S2) confirming the absence of a known cell cycle
regulator in hiPSC.
Finally, the marked vacuolisation seen in hiPSC-
erythroblasts (Fig. 3d) was investigated, as this could in-
dicate defects in the autophagolysosomal pathway that
are critical to terminal differentiation of erythroblasts to
reticulocytes [40, 41]. We found that many of the genes
that encode for proteins that regulate autophagy were in
cluster 1 with significantly reduced expression in hiPSC-
erythroblasts on day 14 when compared with adult-
erythroblasts (Fig. 6c). For example, one of these genes
(VCPIP1/p97) is required for the segregation of organ-
elles into lysosomal compartments, removal of autopha-
golysosomes enriched with light chain 3 [42] and





Fig. 2 (See legend on next page.)
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regulation of mitosis [43]. Another (TRIM58) facilitates
erythroblast enucleation by inducing dynein degradation
[44]. These profiles strongly suggest dysregulation of the
lysosomal degradation pathway in erythroblasts derived
from hiPSCs.
Discussion
The work described substantially extends our prior de-
scription of human erythropoiesis [25], offering a more
fine-grained analysis and comparison of the gene expres-
sion program from three erythroid progenitor sources.
Interestingly, 32 % of the newly identified differentially
expressed genes are captured in SMART clusters. These
include 168 genes co-ordinately regulated with one of
the erythroid regulators GATA1, TAL1, KLF1 and EPOR.
An example is co-clustering of GSK3A, MTF1, ZNF175,
MRFAP1L1, REXO2 and LIN37 with KLF1 in cluster 25
(Additional file 4: Table S2 and Additional file 15: Figure
S11) therefore allowing for the potential to identify novel
regulators during erythropoiesis in vitro.
Gene expression analysis of adult or cord data re-
vealed very similar gene expression programs, irrespect-
ive of culture media or cell origin, consistent with a
previous report of modest differences between fetal and
adult erythroid gene expression programs [45, 46].
However, comparison of gene expression during eryth-
roid differentiation from hiPSCs and adult blood
showed substantially different modules of co-regulated
genes that correlate with phenotypic differences be-
tween the generated erythroid cells (Figs. 4, 5, and 6;
Additional file 16).
We selected our final samples based on their proxim-
ity to the point of nuclear extrusion and enucleation,
after which comparative studies would require post-
transcriptional or proteomic analyses [23, 47]. Thus we
are able to identify gene expression dynamics relevant to
the condensation, movement and eventual extrusion of
the nucleus from the developing erythroid cell, a
poorly understood but critical process for translational
applications of in vitro erythropoiesis [48].
The contribution of EPO to gene expression is con-
firmed by early up-regulation of TIMP1, regulated by
EPO via the classical erythroid TF GATA1 [49]. We cap-
ture the emergence of the erythroid program, with up-
regulation of erythroid-associated genes such as the TFs
GATA1, TAL1, KLF1, BCL2L11 and GFI-1B (Additional
file 4: Table S2) and down-regulation of the TFs FOS,
FOSB, JUN, JUNB and JUND (Additional file 4: Table S2
and Additional file 14: Figure S10A) which may down-
regulate the AP-1 transcription factor complex. We also
identified the induction of known direct transcriptional
targets of GATA1 and KLF1 such as ALAS2 (Additional
file 6: Figure 5A) [50]. So our data comparing day 0 and
day 4 samples tracks the emergence of the erythroid pro-
gram under control of known key regulators. In contrast,
there are fewer differentially expressed genes between day
(See figure on previous page.)
Fig. 2 Gene expression during erythroid differentiation from adult and cord blood stem cells. a PCA of DE gene expression in cord blood- (CB-) derived
differentiations in SEM-F. Genes were selected if they were DE between any two AB populations, or between any two CB populations (Additional file 5:
Table S3A). The union of these two DE gene sets were then used to arrange the samples in the PCA, clustering the CB-erythroblasts together with the
AB-erythroblasts shown in Fig. 1. CB-erythroblast populations were isolated with the same gating strategy used for AB-erythroblasts. The Euclidean
distances relating to this PCA are available in Additional file 19: Table S7. b Hierarchical clustering analysis of the same AB or CB DE gene set, clustering by
Euclidean distance and by gene. The colour bar on the left hand side denotes clusters of co-regulated genes. c The number of DE transcripts between
AB-erythroblasts and the same CB-erythroblast population is shown to examine the fold change at each point during erythropoiesis. Blue bars depict genes
that are expressed more abundantly in CB-erythroblasts, and red, in AB-erythroblasts. d Mean expression values of selected key erythroid genes during
erythropoiesis in SEM-F, +/- standard error of the mean. ACTB and PAFAH1B2 were used to normalise the data since they were consistently expressed
throughout erythropoiesis in this data (Additional file 4: Tables S2)
Table 3 Comparison of the gene expression changes between samples in the AB-erythroblasts and CB-erythroblasts during
maturation
Expression change Sample d0 : d7- d7- : d7+ d7+ : d14++
Upregulated Adult 828
(60 % shared in CB)
30
(0 % shared in CB)
413
(34 % shared in CB)
Downregulated Adult 710
(65 % shared in CB)
35
(0 % shared in CB)
1331
(37 % shared in CB)
Upregulated CB 872
(53 % shared in Adult)
0
(0 % shared in CB)
174
(80 % shared in Adult)
Downregulated CB 982
(56 % shared in Adult)
0
(0 % shared in Adult)
568
(86 % shared in Adult)
The number of DE genes from each source, and the degree to which these genes are similarly DE from the other source, is shown
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4, 7, 10 and day 12 samples, thus indicating a stable pat-
tern of gene expression as early erythroblasts undergo
rapid cell division.
Crucially, our data from hiPSCs showed that expression
of the key regulators SOX6, MYB and BCL11A and the glo-
bin genes are quite consistent with specification of primi-
tive erythropoietic cells [36, 37, 51]. Such observations of a
putative primitive erythroid gene expression program in the
hiPSC setting, although known from globin profiling [6],
have not until now been described dynamically during
erythropoiesis. The program-level of expression changes we
describe here may have implications for generation of
clinically-useful in vitro-derived RBC products. Whilst defi-
ciency in expression of BCL11A, and expression of fetal
globin, is therapeutically attractive for treatment of hemo-
globinopathies (reviewed in [52]), primitive erythroid cells
do not efficiently enucleate in vitro without the support of
macrophages [4, 53]. In vivo, enucleating primitive eryth-
roid cells are in close contact with macrophages in the fetal
liver or human placenta or may enucleate in the circulation
[3, 4]. Hence, it is not surprising that suspension-culture
erythroid cells derived from hiPSCs fail to efficiently enu-
cleate in vitro in our experiments. Stimulating enucleation
may become possible, but we saw no enucleation when our
hiPSC derived erythroid cells were co-cultured with a mur-
ine stromal cell line known to support enucleation [54]
(Fig. 3d).
One report has suggested that the enucleation deficiency
in these hiPSC lines may be due to the absence of cytoskel-
etal proteins such as α-catenin and β-tubulin, that subse-
quently disrupt remodelling of the cell membrane during
enucleation [23]. Remarkably, some enucleation is observed
from hiPSC-derived hematopoietic cells specified by certain
TF combinations [55]. These authors reported definitive
erythropoiesis in vivo following transplantation of hiPSC
lines specified via a combination of constructs coding for
ERG, HOXA9, RORA, SOX4 and MYB. Interestingly,
reported globin switching of nucleated hiPSC-derived
erythroid cells following transplantation in vivo implies that
transition to a definitive globin gene expression program is
dependent on contextual cues [24, 55]. This has been sup-
ported by in vitro induction of hemoglobin A using specific
stromal layers [14].
Derivation of a definitive erythroid program from hiPSCs
in vitro potentially presents a significant challenge as key
regulators of this switch from the primitive program have
not been identified. More fruitful approaches arise from
direct specification of the cells emerging from embryoid
bodies to the definitive lineage [24, 56]. An alternate route
to successful specification of hiPSCs to the definitive
lineage involves inhibition of activin/nodal signaling and
activation of the WNT/β-catenin pathway [57].
Within our data, there is some evidence that the WNT/
β-catenin pathway may contribute to the aberrant pheno-
type observed when erythroblasts are derived from hiPSC.
Among the genes that encode key players within this
pathway, i.e., the Frizzled receptor family (FZD4, 7 and 8),
LR6, AXIN and APC, only GSK3A is differentially regu-
lated between adult and hIPSC derived erythroblasts.
GSK3α (glycogen synthase kinase 3 alpha) forms a com-
plex with proteins encoded by AXIN and APC to induce
ubiquitination of β-catenin and inhibit continued stem cell
expansion (reviewed in [58, 59]. This protein also phos-
phorylates and inhibits the TFs MITF, TFEB and TFE3
that upregulate genes required for the formation of lyso-
somes (see [60] for review). Intriguingly, in our dataset
GSK3A is significantly upregulated in adult derived eryth-
roblasts compared with those from hiPSC throughout cul-
ture (Additional file 10: Table S5B) and its expression co-
clusters with erythroid regulators (Additional file 4: Table
S2 and Additional file 15: Figure S11). Therefore, deter-
mining whether the post translational control of TFs by
GSK3a in erythroblasts regulates expression of the autop-
hagolysosomal genes found in cluster 1 of our SMART
analysis (Fig. 6) may shed more light on how to overcome
enucleation deficiencies in erythroid cultures from hiPSC.
It is possible that re-specifying emerging hematopoietic
cells into a definitive fate correlates with an increased rate
of spontaneous enucleation for in vitro erythropoiesis with-
out helper cells. However apparently definitive erythroid
cells generated from hiPSC (expressing fetal hemoglobin)
still show enucleation that is 30 % of that observed in
erythroid cultures derived from cord blood HSPCs [56].
Therefore, further analysis of the association between
persistent vacuolisation and aberrant expression of genes in
hiPSCs that are involved in protein degradation, lysosomal
clearance and cell-cycle checkpoints is required to reveal
how to enhance reticulocyte production in vitro.
Erythropoiesis from hiPSCs is always limited by the
relative lack of proliferation compared to that seen in
adult and neonatal erythroblasts. We noted that c-KIT
Table 4 Gene ontology analysis of the DE genes in both
AB-erythroblasts and CB-erythroblasts
Comparison GO category Corrected Hyp.
p Value
Upregulated d0 to d7- Cell cycle 3.9 e-55
Porphyrin metabolism 1.3e-9
Downregulated d0 to d7- Chemokine signalling 4.1e-17
Antigen processing 1e-11
Hematopoietic lineage 7e-7
Downregulated d7+ to d14 Ribosome biogenesis 1.6e-8
Purine metabolism 2.7e-8
Pyrimidine metabolism 5.5e-5
Highly-enriched ontologies are shown, together with the more stringent
corrected hypergeometric (Hyp) p-values produced by GeneCoDis
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was not induced during hiPSC-derived erythropoiesis,
but was in adult and cord blood-derived cells where c-
KIT expression resembled that in primitive erythroblasts
[61]. Failure to respond to SCF might be predicted to
confer a profound difference in proliferative response
from hiPSC-derived erythroblasts, as response to SCF
present in the medium during the first 11 days of culture
would stimulate adult and cord blood erythroblast pro-
liferation in SEM-i (Fig. 3). Notably, reduced expression
of c-KIT resulting from mir221 and mir222 action is as-
sociated with markedly reduced erythroid cell prolifera-
tion [62]. Enforced expression of c-KIT in hiPSCs did
A B
C D
Fig. 3 The gene expression profile of hiPSC derived erythroblasts is independent of the media used as evidenced by comparison of erythroid
differentiation in SEM-i with SEM-F. a Hierarchical clustering analysis by Euclidean distance of adult erythroid differentiations performed using media for adult
derived HSPCs (SEM-F), or hiPSC conditions (SEM-i). The gene set used contained genes which were DE during maturation in any of the two media settings
(Additional file 20: Table S4). The colour bar on the left hand side denotes clusters of co-regulated genes. Samples cluster together by time and by the
immunophenotype of the developing erythroid cells. There are no coherent subclusters formed according to the type of media used. b PCA of the samples
shown in (A) with the same gene set. Populations are represented as follows: SEM-F, red symbols; SEM-i, blue symbols; d0 CD34+, black circles; day 4 CD36
+CD71+CD235a−, triangles; day 7 CD36+CD71+CD235a−, thin diamond; day 7 CD36+CD71+CD235a+, square; day 7 CD71+ beads, fat diamond; day 14 CD71
+CD235a+, pentagon; day 14 CD235a+ beads, hexagon. c Proliferation in SEM-i of erythroid AB-erythroblasts (black triangles), CB-erythroblasts (green squares)
and hiPSC-erythroblasts (blue) where hiPSCs were specified from CD34+ peripheral blood (squares), erythroid cells (triangles) or fibroblasts (circles). Error bars
indicate standard error of the mean of 3 or more cultures. d Morphological changes observed in erythroblasts of hiPSC and AB origin cultured in SEM-i.
Representative images of Giemsa-benzidine stained cytospins of cultures on day 7, day 14 and day 20. Scale bar is ~10 μm. “m” is the stromal cell line
MS-5. AB-derived differentiations, cultured further until day 20/21, were typically 70-80 % enucleated (see also Additional file 21: Figure S12), whereas the
hiPSC-erythroblast cultures failed to enucleate
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appear to allow moderately increased proliferation, con-
sistent with a role for c-KIT signalling in the much
greater proliferative responses of adult cells to SCF in
the culture medium. Understanding how to more effi-
ciently express functional cell surface c- KIT in hiPSCs
will be key to further investigating this important poten-
tial axis for intervention during in vitro differentiation
protocols.
Other work has shown that c-KIT stabilises β-catenin
expression [63] which forms a complex with LEF-1 to
induce cyclin D1 expression [64]. Both cyclin D1 and
LEF-1 are significantly downregulated in hiPSC erythro-
blasts (Additional file 10: Table S5B) suggesting that
other regulators of cyclin D1 or LEF-1 should also be
studied to further improve proliferation of hIPSC de-
rived erythroblasts.
We note that erythroblasts derived from apparent
definitively-specified hiPSCs [56] still demonstrate a pro-
found proliferation defect; it is unclear whether c-KIT or
GSK3-a expression were induced during erythropoiesis
in this setting, further demonstrating the value of our
dynamic gene expression analysis compared to steady-
state observations.
Conclusions
The comparative transcriptomics of erythroid cells de-
rived from hiPSC, neonatal and adult progenitor cells
have been highly informative but only partially represent
the orchestration of protein expression required to pro-
duce viable and functional mature erythroid cells.
Tissue-specific splicing of pre-messenger RNA (mRNA)
produces isoforms of cytoskeletal and transport proteins
that are required for function of mature erythrocytes
[65, 66]. Alternative splicing can also introduce prema-
ture termination codons and such splicing switches ap-
pear to exert dramatic changes during the latter stages
of RBC development [67, 68]. Moreover, production of
microRNAs that themselves affect transcript levels are
also known to differ between these developmental pro-
grams. These post-transcriptional levels of control are
being analysed separately (manuscripts in preparation).
The data presented in this paper and detailed in the
Supplementary Files highlight the disparities between
erythropoiesis in vitro from diverse stem/progenitor cell
origins and have generated a series of hypotheses and re-
sources for further dissection of the programs of eryth-
roid development.
Methods
All reagents were obtained from Sigma Aldrich unless
stated otherwise. Peripheral blood mononuclear cells were
obtained from blood donated to the National Health Service
Blood and Transplant (NHSBT; http://www.nhsbt.nhs.uk/)
following written consent and their use approved by the
National Health Service Oxfordshire Regional Ethical
Committee.
Cell culture
Human primary differentiating erythroblasts derived
from adult peripheral blood lymphocyte cones (AB)
(NHS Blood and Transplant) or cord blood (CB) were
obtained with informed consent in accordance with the
Declaration of Helsinki.
Erythroblasts were cultured using a three-phase liquid
culture system [69] with modifications (Table 1).
Erythroid progenitors were cultured in two Standard
Erythroid Medium modifications: SEM-F (used for AB-
erythroblasts and CB-erythroblasts), or SEM-i (used for
AB-erythroblasts and hiPSC-erythroblasts). Briefly, mono-
nuclear cells were obtained from AB or CB by Ficoll-
Hypaque density-gradient centrifugation. CD34+ erythroid
progenitors were isolated using magnetic beads (Miltenyi)
and their purity (>90 %) verified by flow cytometry. Cells
were seeded at 2 x 105 cells/ml in standard erythroblast cul-
ture medium containing 2 % Fetal Bovine Serum (FBS)
(SEM-F). Cells were washed to remove cytokines between
media changes. HiPSCs were established from fibroblasts
or hematopoietic cells transduced with OCT4, SOX2 and
KLF4 [14]. Erythroblasts were generated by modifying a
published protocol [18] in medium optimised for hiPSC-
derived erythroblast culture (SEM-i) (Table 1). Briefly, the
co-cultured hiPSCs and OP9 cells were harvested after 8
Table 5 A breakdown of the number of DE genes during adult erythropoiesis in each medium type









(89 % shared with SEM-i)
865
(70 % shared with SEM-i)
1174
(79 % shared with SEM-i)
38 30 416
Downregulated SEM-F 953
(84 % shared with SEM-i)
1961
(81 % shared with SEM-i)
695
(82 % shared with SEM-i)
23 34 1335
Upregulated SEM-i 1349
(70 % shared with SEM-F)
832
(73 % shared with SEM-F)
NA NA NA NA
Downregulated SEM-i 921
(86 % shared with SEM-F)
2324
(69 % shared with SEM-F)
NA NA NA NA
NA not applicable
Numbers of genes up- or down-regulated between developmental stages in each medium setting are given, with the % similarly regulated in the other media
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days and disaggregated as previously described [18]. Cells
were typically cultured for 14 days in the four-phase SEM-i
culture protocol. Before transfer from Phase I SEM-i to
Phase II, hiPSC-derived erythroblasts were gently disaggre-
gated by pipette propulsion before separation of
hematopoietic cells from OP9 cells using 20% Percoll gradi-
ents (Additional file 17: Figure S1). Some cultures were ex-
tended to day 21 to assess enucleation. HiPSC-derived
erythroblast cultures were co-cultured with the murine
stromal cell line, MS5, in SEM-i Phase IV medium (Table 1).
Extended culture of erythroblasts derived from AB contin-
ued in Phase III SEM-F. Cell density did not exceed 106
cells/ml throughout culture.
Isolation of enriched populations
Cells were separated into enriched populations based on
cell surface expression of CD34, CD36, CD71 and
CD235a using flow cytometry or magnetic beads
(Additional files 1 and 18). AB- and CB-derived erythro-
blasts were stained and sorted on a MoFlo II (Beckman
Coulter) using anti–CD36-PE (BD Biosciences; for eryth-
roblasts cultured for between four and seven days),
anti–CD71-FITC (Dako), anti–CD235a-APC (BD Biosci-
ences; for erythroblasts cultured between four and 12
days), and anti–CD235a-RPE (Dako; for erythroblasts
cultured for 14 days). Cells were cultured from three in-
dependent samples for each population isolated. Tripli-
cate samples of total CD34+ cells were also obtained on
day 0 for RNA extraction.
Fluorescence-activated cell sorting (FACS) was used to
isolate triplicate samples of discrete populations of cells
similar in maturity and lineage. Debris and dead cells
were excluded by examining forward scatter and DAPI-
staining. A pulse-width gate in side scatter was applied
to exclude doublets. Sort gates were defined by first set-
ting a gate on the expression profile of the population of
interest: CD36 + CD71+ on day 4, CD36 + CD71 +
CD235a- and CD36 + CD71 + CD235a + on day 7 (day 7-
and day 7+), and CD71 + CD235a + on days 10, 12 and
14 (day 10+, day 12+ and day 14+). Representative plots
are shown in Additional file 1: Figure S2. These gates
were then applied to the forward scatter versus side scat-
ter dot plot to define a population of cells showing simi-
lar size. At day 0, AB-, CB- and hiPSC-derived HSPCs
were isolated using CD34-beads (Miltenyi). HiPSC-
derived hematopoietic progenitors were also isolated
using CD31 beads at day 0 to incorporate all possible
sources of erythroid progenitors. As insufficient cell
numbers were obtained for FACS sorting of erythro-
blasts derived from hiPSCs, CD71 and CD235a-specific
magnetic beads were used to isolate hiPSC-erythroblast
populations at days 7 and 14 respectively. AB-
erythroblasts were isolated using these beads for direct
comparison with hiPSC-derived erythroblasts. The
purity of each FACsorted or bead sorted population was
typically > 90 %. The sort gates for isolated populations
are shown in Additional files 1 and 18.
Maturation of erythroblasts was monitored by staining
cytospin preparations from 5x104 cells with Wright-
Giemsa and assessed using light microscopy. To visualise
hemoglobin expression, cytospins were stained with 1 %
O-dianisidine in methanol and counterstained with 10 %
Giemsa (BDH) (Additional file 1: Figure S2B).
RNA extraction
Total RNA including miRNA was extracted using mir-
Vana (Thermofisher) according to the manufacturer’s in-
structions. RNA quality and quantity was assessed using a
Qubit fluorimeter (Thermofisher Scientific), a NanoDrop
spectrophotometer (Thermo) and an Agilent Bioanalyzer
2100 (Agilent Technologies). RNA integrity numbers were
in the range 8.7-10. Before target preparation for hybrid-
isation to Affymetrix Human Transcriptome 2.0 (HTA2.0)
arrays (Affymetrix), RNA was treated with Turbo DNA-
Free DNAse (Thermofisher Scientific).
Array hybridisation
The target was prepared from 100ng total RNA for hy-
bridisation to Affymetrix GeneChip Human Transcrip-
tome 2.0 ST microarrays (HTA2) using the Ambion WT
protocol (Thermofisher Scientific) and Affymetrix label-
ling and hybridisation kits (Affymetrix). Labelled DNA
mean yield was 13.5 μg (minimum: 8.5 μg; maximum:
20.5 μg). HTA2 arrays were hybridised with 5 μg of la-
belled DNA.
The Affymetrix GeneChip Fluidics Station 450 was
used to wash and stain the arrays with streptavidin–
phycoerythrin, according to the standard protocol for
eukaryotic targets (IHC kit, Affymetrix). Arrays were
scanned with an Affymetrix GeneChip scanner 3000 at
570 nm.
Quantitative PCR
Validation of array data to confirm expression of genes was
achieved following DNAse treatment of RNA and synthesis
of cDNA using either the High Capacity cDNA Reverse
Transcription Kit or the SuperScript® VILO™ cDNA
Synthesis Kit (both from ThermoFisher Scientific). Semi-
quantitative polymerase chain reaction (qPCR) was per-
formed using TaqMan reagents and assays (ThermoFisher
Scientific). Data was normalised using ACTB and
PAFAH1B2 as reference genes since they were con-
sistently expressed throughout erythropoiesis in our
data (Additional file 4: Table S2). This qPCR data is
shown in (Additional file 7: Figure S5B) and (Additional
file 13 :Figure S10B).
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A d0 34+
A d7 CD71+ beads
A d14 CD235a+ beads
hiPSC d0 34+
hiPSC d7 CD71+ beads















































































































































Fig. 4 (See legend on next page.)
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Enforced KIT expression in hiPSCs
Emerging hiPSCs at the point of disaggregation from OP9
co-culture were transduced with GFP+ lentivirus express-
ing the c-KIT open reading frame, or the empty vector
(LV-165; both Genecopoiea) packaged essentially as
described elsewhere [70]. HiPSCs were cultured as de-
scribed above for three days before sorting of GFP+ CD235
+ erythroid cells using FACS. The sorted hiPSCs were cul-
tured on as described in 50 μl of medium in 96-well format
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Fig. 5 Transduction of hiPSC hematopoietic progenitors with lentivirus expressing c-KIT enhances erythroblast expansion. a Proliferation of hiPSC-
erythroblasts transduced with either the GFP tagged lentiviral construct (GFP c-KIT) or with the control vector (GFP) was monitored after selection of
GFP positive cells by FACS on day 2 of hiPSC erythroblast culture. Results from 2 independent experiments are shown in (i) and (ii). b Increased
expression of c-KIT in erythroblasts grown from hiPSC progenitors transduced with the GFP c-KIT lentivral construct. Error bars are SDs of quadruplicate
measurements by semi-quantitative PCR from cells taken on day 10 of culture showing a 1.5 fold increase that is comparable to the increase in cell
expansion. c Protein expression of c-KIT at the surface of erythroblasts grown from hIPSC progenitors transduced with the GFP-c-KIT or control vector
expressing GFP alone. GFP-c-KIT erythroblasts collected at the end of experiment (i) show a small increase in c-KIT expression where mean fluorescence
intensity (MFI) is 47 compared with control MFI of 37 and the proportion of c-KIT positive cells is also modestly increased (highlighted in blue)
(See figure on previous page.)
Fig. 4 Elaboration of functional gene clusters in erythroid cells derived from adult and hiPSC progenitors in SEM-i. a PCA of genes differentially
expressed in AB-erythroblasts (red symbols) or hiPSC-erythroblasts (blue symbols) during erythroid maturation in SEM-i. The gene set was any gene DE
during maturation of erythroblasts from either source. The Euclidean distances relating to this PCA are available in Additional file 19: Table S8.
b Expression profiles of globin genes in AB-erythroblasts and hiPSC-erythroblasts. Mean expression +/- standard error of the mean is plotted.
c Expression profiles of genes encoding proteins with key roles in the regulation of erythroid development in the adult and hiPSC-derived settings.
Mean expression +/- standard error of the mean is plotted. d Hierarchical clustering analysis by Euclidean distance of AB-erythroblasts and
hiPSC-erythroblasts, clustered by gene only. The colour bar on the left hand side denotes clusters of co-regulated genes. e Gene expression profiles for
c-KIT and NFIA in AB-erythroblasts and hiPSC-erythroblasts. Mean expression +/- standard error of the mean is plotted. Given these findings, we
validated the microarray-based gene expression measurements of selected transcripts using quantitative RT-PCR (in Additional file 13: Figure S10B)
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Fig. 6 (See legend on next page.)
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with fresh medium if they exceeded 3 x 105 cells/ml. At the
end of culture, cells were collected to measure c-KIT (PE
conjugated anti-CD117, antibody clone AC126 (Miltenyi)
and to perform qPCR. Flow cytometry was used to deter-
mine relative numbers of cells expressing c-KIT using the
control steps described for FACsorting. Q-PCR was used as
described above but with GAPDH as reference gene.
Data analysis
Intensity values were determined using GeneChip Operat-
ing Software (Affymetrix) and normalised by the Robust
Multiarray Average algorithm using Affymetrix Expression
Console software. Statistical analysis of differential expres-
sion was conducted using the Linear Models for
Microarray Data package from the Bioconductor suite in
R (http://www.bioconductor.org/). The B values, p-values,
and fold changes were used to select differentially
expressed (DE) genes reaching a minimum linear expres-
sion value of 100 in all replicates of at least one sample
group (p ≤ 0.01, fold change (FC) ≥ 2, B > 2.945). Data was
normalised with ACTB and PAFAH1B2 as control genes.
Principal component analysis (PCA) was conducted and
displayed using Python packages. Hierarchical clustering
(HC) analysis was performed using Python SciPy. Heat
maps were generated using Python matplotlib.
For more sophisticated clustering analysis, we combined
three advanced clustering algorithms, namely splitting mer-
ging awareness tactics (SMART) [31], binarisation of con-
sensus partition matrix (Bi-CoPaM) [30], and Bimax [71],
in the consensus clustering framework to form two stages
of consensus and to produce clusters of consistently co-
expressed genes with higher resolution in three datasets, i.e.
adult blood, cord blood and hiPSC datasets. We clustered
each dataset separately using the SMART algorithm 100
times. Then we combined the 100 results of each dataset
using Bi-CoPaM in the first stage. In the second stage, we
used Bimax to combine three intermediate consensus-
clustering results for individual datasets and discover the
genes that consistently co-express in all three datasets.
SMART and Bi-CoPaM algorithms were implemented in
MATLAB, and Bimax from the biclust package in R. We
took the median of the replicates in each population.
Therefore, we have 11 population points for adult blood
(namely d0, SEM-F d4, SEM-i d4, SEM-F d7-, SEM-F d7+,
SEM-F d7 BEADS, SEM-i d7 BEADS, SEM-F d10, SEM-F
d14 BEADS, SEM-F d14, and SEM-i d14; for ease of visual-
isation to maintain an odd number of populations, a 12th,
SEM-F d12, was omitted); 3 population points for cord
blood (namely d0, d7 and d14); and 3 population points for
hiPSC (namely d0, d7 and d14). There are no data-
dependent parameters to set. The maximum number of
merges in SMART is 10; the tuning parameter in Bi-
CoPaM is 0, meaning that a gene is assigned to only one
cluster; the parameter for the minimum number of
columns is 3, which is the number of datasets, meaning
that the resulting clusters must include only the genes
co-expressing in all three datasets. Biopython [72] was
employed to fetch 1 kb of genomic DNA sequence
upstream of the transcriptional start sites (TSS) of each
gene in the cluster. MEME suite was used for transcription
factor binding site (TFBS) analysis, seeking homology with
motifs in the Jolma database [73]. Differentially-expressed
genes were examined for enriched functional ontologies
using GeneCoDis [74].
Additional files
Additional file 1: Figure S2. Erythroblast maturation and study design. A)
Erythroid differentiation was induced in adult peripheral blood CD34+ cells in
SEM-F (Table 1) from three independent samples for each population isolated.
Triplicate samples of total CD34+ cells were also obtained on day 0 for RNA
extraction. B) Fluorescence-activated cell sorting (FACS) was used to isolate
triplicate samples of discrete populations of cells similar in maturity and
lineage. A fraction of each sample was examined morphologically as shown
using Wright stain to confirm the isolation of populations of cells which had
progressively developed changes in size, nuclear-cytoplasmic ratio, cytoplasmic
staining and nuclear positioning typical of terminal erythropoiesis. Scale bar
equates to 10 μm. C) Cell proliferation in culture in SEM-F. Five representative
samples are shown tracking fold change in total cell number over time,
allowing for dilution during culturing schedules. D) Analytical workflow. Linear
Models for Microarray Data was used for statistical analysis of differential
expressed (DE) genes (B value at least 2.945, p-value below 0.01, fold change
at least 2, and expression levels in all replicates at any population at least 100).
The resulting DE genes were analysed by PCA. To show the global view of
expression patterns, the DE genes were also clustered using unsupervised
hierarchical clustering and displayed using heat maps. More sophisticated
clustering was conducted to select consistently co-expressed genes in adult
blood, cord blood, and hiPSC datasets. The consensus clustering framework
combining SMART, Bi-CoPaM and Bimax is described in the Methods section.
Thereafter, the GO term and upstream transcriptional factor binding site
analyses of the resulting clusters were conducted. (PDF 599 kb)
Additional file 2: Tables S1A and S1B. Both relate to Fig. 1.
(XLSX 9540 kb)
(See figure on previous page.)
Fig. 6 Differential expression of co-ordinately regulated genes relevant to erythroid expansion and terminal differentiation identified using SMART.
a Standard hierarchical clustering analysis by Euclidean distance of the union of DE genes from all cells of origin, in all media, clustered by gene
only, of all samples utilised in the study, regardless of medium type or cell-of-origin, to visualise clusters of robustly co-regulated genes. The
colour bar on the left hand side denotes clusters of co-regulated genes. b Transcription factor binding site analysis of 1kb of genomic DNA
sequence upstream of the TSS for genes in the DNA repair/cell-cycle cluster. Matches from MEME/TOMTOM analysis are depicted: upper panels
are motifs from the database; lower panels are the enriched motif detected within cluster 20 from our SMART analysis. Vertical axes are scaled to
2 bits in all images, and horizontal axes show sequential bases in the relevant motifs. c Examples of genes in SMART cluster 1, important in autophagic
processes, which are differentially expressed between AB-erythroblasts and hiPSC-erythroblasts during the last phases of differentiation
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Additional file 3: Figure S4. Gene expression centroids from the adult
FBS erythropoiesis data as depicted in Fig. 1B. Replicate samples are
plotted as individual data points. Error bars indicate the standard
deviation of expression observed. (PDF 130 kb)
Additional file 4: Table S2. Linear expression values of all genes from
all HSC sources studied that exceed a threshold linear expression level of
100 in all replicates of at least one population. (CSV 17480 kb)
Additional file 5: Tables S3A and S3B. Both relate to Fig. 2.
(XLSX 6267 kb)
Additional file 6: Figure S5A. Microarray gene expression profiles for
selected genes with roles in erythropoiesis, in the AB-erythroblasts and
CB-erythroblasts cultured in SEM-F. Mean expression ± standard error of
the mean is plotted. (PDF 303 kb)
Additional file 7: Figure S5B. Relates to Fig. 2. Quantitative PCR
validation of fold changes in gene expression observed by microarray. For each
DE gene, the left hand graph shows the change in expression at each erythroid
culture stage observed by microarray (“HTA”), and the right hand graph shows
the same FC verified by qPCR (of 2 representative samples in quadruplicate);
mean± SD. A logarithmic scale (base 10) is used. Erythroid Stage plotted on the
x-axes: d0, day 0 (CD34+); d7-, day 7- (SEM-F, CD71 + CD235a-); d7+ (SEM-F,
CD71+ CD235a+) d14, day 14 (SEM-F, CD235a+). (PDF 31 kb)
Additional file 8: Figure S6. HCL analysis of the union of DE genes
during AB-erythroblast maturation in SEM-F or SEM-i, as described in the
manuscript. HCL was prepared by Euclidean distance clustering by gene
and by sample. The colour bar on the left hand side denotes clusters of
co-regulated genes. (PDF 4146 kb)
Additional file 9: Figure S7. The effect of different media types on gene
expression in maturing AB-erythroblasts The numbers of genes DE between
replicates of the same populations (defined by the sort gates in Additional file
1: Figure S2 and Additional file 18: Figure S3) are plotted. Those with lower ex-
pression in the first medium indicated are shown in blue; those with higher
expression in red, within the ranges of fold changes indicated on the x axis for
SEM-F versus SEM-i. The numbers of genes DE between AB-erythroblasts at
the same stages in different media are insignificant compared with the large
number of genes expressed in AB-erythroblasts at any one stage. (PDF 44 kb)
Additional file 10: Tables S5A and S5B. Both relate to Fig. 4 and
contain annotations, linear expression values, statistical parameters and fold
changes of differentially expressed genes between different populations
during maturation of Adult and hiPSC Erythroblasts in SEM-i. Inclusion criteria
for differentially expressed genes: B value of at least 2.945, p-value below 0.01,
fold change of at least 2, and expression levels in all replicates at any popula-
tion of at least 100. Erythroblasts were cultured for between 0 and 14 days
(d0-d14). Upregulated and downregulated genes are listed separately in
Table S5B. (XLSX 5326 kb)
Additional file 11: Figure S8. Gene expression profiles for selected
genes with roles in heme biosynthesis, in AB-erythroblasts and hiPSC-
erythroblasts cultured in SEM-i. Mean expression +/- standard error of the
mean is plotted. (PDF 295 kb)
Additional file 12: Figure S9. A) Gene ontology analysis of genes
regulated during the first 7 days of culture of AB-erythroblasts and
hiPSC-erythroblasts in SEM-i. Significantly-scoring ontologies are shown,
together with the more stringent corrected hypergeometric p-values
produced by GeneCoDis, and the number of DE genes in each category
from both cell types. B) Numbers of genes with roles in the cell cycle which
are up-regulated in AB-erythroblasts and hiPSC-erythroblasts in SEM-i
between days 0 and 7 are indicated, showing the numbers up-regulated
from both sources or uniquely in each. (PDF 408 kb)
Additional file 13: Figure S10B. Quantitative PCR validation of fold
changes of selected genes observed by microarray. For each DE gene, the
left hand graph shows fold changes (FC) relative to AB day 0 observed by
microarray (“HTA”), and the right hand graph shows the same FC verified by
QPCR (2 repeats of 2 representative samples in triplicate). A logarithmic
scale (base 10) is used. Time is plotted on the x-axes: d0, day 0 (CD34+);
d7, day 7 (SEM-i, CD71+); d14, day 14 (SEM-i, CD235a+). (PDF 383 kb)
Additional file 14: Figure S10A. Gene expression profiles for selected
genes with roles in the control of erythropoiesis, in AB-erythroblasts and
hiPSC-erythroblasts cultured in SEM-i. Mean expression ± standard error of
the mean is plotted. (PDF 298 kb)
Additional file 15: Figure S11. Expression profiles of genes within all
clusters of >30 members derived from the SMART analysis of the global
dataset are shown. Top row AB-erythroblasts, middle row CB-
erythroblasts, bottom row hiPSC-erythroblasts. (PDF 287 kb)
Additional file 16: Figure S13. HCL analysis of the union of DE genes
from all cells of origin, in all media as described in the manuscript. HCL was
prepared by Euclidean distance clustering by gene and by sample. A denotes
adult, C denotes cord blood, and iPS denotes hiPSC-derived erythroid cultures.
Samples isolated using paramagnetic beads rather than flow sorting are
labelled. The colour bar on the left hand side denotes clusters of co-regulated
genes. (PDF 5324 kb)
Additional file 17: Figure S1. The cell surface phenotype of progenitors
derived from hiPSC co-culture on OP9 stromal cells. The proportion of cells
that express cell surface proteins used to identify hematopoietic progenitors
are shown in (A) on day 0 before transfer to SEM-i culture where (i) the CD31
+ gate comprises more than 90 % CD34+ when CD43+ and CD43- are
combined and (ii) only 3 % of CD34 + CD31- cells express the hematopoietic
lineage marker CD43. On day 3 shown in (B) a Percoll gradient has removed
OP9 cells so that (i) the viable DAPI negative culture grown on is (ii) enriched
with approximately 98 % CD43+ hematopoietic cells and 30 % of cells are
typically CD34+ some of which also express CD45. This indicates enrichment
of hematopoietic multipotent progenitors during the first phase of culture in
SEM-i as described previously by Dias et al. [18]. (PDF 144 kb)
Additional file 18: Figure S3. Isolation of erythroid precursors at defined
stages of culture and derived from different sources of hematopoietic
progenitors. A) Eryhthroblasts derived from cord blood CD34+ cells and
cultured in SEM-F were enriched by FACs and gene expression compared to
that from adult derived erythroblasts isolated using the same sort gates shown
in Figure S2. The CD markers expressed by erythroblasts in the collected
fractions are highlighted in blue. B) Erythroblast numbers derived from hIPSC
progenitors grown in SEM-i were not sufficient for FACSorting and so
populations based on time and phenotype were isolated using magnetic
bead isolation. Day 7 erythroblasts were isolated using CD71 specific beads to
target early precursors and Day 14 erythroblasts were isolated using beads
specific to CD235a to target more mature erythroid cells. C) For comparison
with hiPSC, CD34+ cells from Adult peripheral blood were cultured in the
same media (SEM-i) and magnetic beads specific to CD71+ and CD235a + also
used to isolate the populations shown on days 7 and 14 respectively. An
example of sort purity achieved after D) use of FACS to obtain CD235a +
CD71+ erythroblasts after 14 days of Adult HSC culture in SEM-F. The R5 sort
gate was used to collect erythroblasts that were 94 % pure based on the
expression of both CD235a and CD71. E) Magnetic beads conjugated to
antibodies specific to CD71 were used on day 7 and beads specific to
CD235a were used on day 14 of erythroid cultures in SEM-i. The purity of cells
collected shown in R3 gate on day 7 or in R4 gate on day 14 is highlighted in
blue. (PDF 190 kb)
Additional file 19: Tables S6, S7 and S8. The Euclidean distances from
the PCAs shown in Figs. 1, 2 and 4 of manuscript. (PDF 96 kb)
Additional file 20: Table S4. Relates to Fig. 3. Annotations, linear
expression values, statistical parameters and fold changes of genes DE (B value
at least 2.945, p-value below 0.01, fold change at least 2, and expression levels
in all replicates at any population at least 100) between different populations
during maturation of Adult Erythroblasts (AB-erythroblasts) in SEM-F or SEM-i,
cultured for between 0 and 14 days (d0-d14). (XLSX 10526 kb)
Additional file 21: Figure S12. Enucleated cells were enumerated from
stained cytospin preparations prepared after extended culture period of 21
days in SEM-F. Samples were analysed before and after CD235a selection on
paramagnetic beads. Observations from 2 independent cultures in SEM-i are
shown from a minimum of 90 cells per culture condition. (PDF 21 kb)
Abbreviations
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